title: The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.
abstract: Atrial fibrillation (AF) is the most common rhythm disturbance in medical practice and represents a very expensive health problem. AF can be managed with the prevention of thromboembolism and either a rate control of rhythm strategy. As both strategies have important limitations, probably a preventative strategy in patients at risk of developing arrhythmia can be a more attractive option. The renin-angiotensin system (RAS) seems to be involved in the genesis of arrhythmia by the following two mechanisms: 1. the induction of atrial fibrosis and structural remodelling by mitogen-activated protein kinase (MAPK) expression and reduction of collagenase activity; 2. the induction of electrical remodelling by shortening of the atrial effective refractory period (AERP) and of the action potential duration. For these reasons it has been hypothesized that angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin-II receptor blockers (ARBs) may play a role in preventing AF recurrence. The aim of the present review was to analyse evidence supporting the usefulness of RAS inhibition in patients with AF in order to focus on which specific subset of patients it would most favour. After reviewing the literature, we conclude that, although many studies and meta-analysis have supported the advantage of RAS block in preventing AF recurrence, it is premature to recommend the use of ACE-Is and ARBs specifically for the prevention of AF. However we believe that as these drugs are safe and manageable, they should be considered the drugs of choice in patients with AF and coexisting clinical conditions such as hypertension, coronary disease, heart failure and diabetes mellitus.
authors.affiliation: Division of Cardiology, Department of Internal Medicine and Cardiovascular Diseases, University of Palermo, Palermo, Italy. novog@mail.unipa.it
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Novo
authors.forename: Daniela
authors.initials: D
authors.lastname: Guttilla
authors.forename: Giovanni
authors.initials: G
authors.lastname: Fazio
authors.forename: Debbie
authors.initials: D
authors.lastname: Cooper
authors.forename: Salvatore
authors.initials: S
authors.lastname: Novo
mesh_terms: D000804:Angiotensin II / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000378:metabolism; D004554:Electric Countershock; D019317:Evidence-Based Medicine; D005838:Genotype; D006801:Humans; D020929:Mitogen-Activated Protein Kinase Kinases / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000804:Angiotensin II; D020929:Mitogen-Activated Protein Kinase Kinases
references.citation: Circulation. 1999 Jun 15;99(23):3028-35
references.pmid: 10368121
references.citation: J Am Coll Cardiol. 1998 Sep;32(3):695-703
references.pmid: 9741514
references.citation: Am J Med. 1995 May;98(5):476-84
references.pmid: 7733127
references.citation: Minerva Cardioangiol. 2007 Jun;55(3):311-5
references.pmid: 17534249
references.citation: J Am Coll Cardiol. 2005 Mar 1;45(5):712-9
references.pmid: 15734615
references.citation: Hypertens Res. 2006 Apr;29(4):277-84
references.pmid: 16778335
references.citation: Circ Res. 1993 Sep;73(3):413-23
references.pmid: 8348686
references.citation: Lancet. 1999 Nov 20;354(9192):1751-6
references.pmid: 10577635
references.citation: Am Heart J. 2006 Jun;151(6):1187-93
references.pmid: 16781218
references.citation: JAMA. 2004 Nov 24;292(20):2471-7
references.pmid: 15562125
references.citation: Arch Intern Med. 1994 Jul 11;154(13):1449-57
references.pmid: 8018000
references.citation: Circulation. 2000 Jun 13;101(23):2678-81
references.pmid: 10851203
references.citation: Cardiovasc Res. 1993 Mar;27(3):341-8
references.pmid: 8490934
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520
references.citation: Circulation. 2002 Jul 16;106(3):331-6
references.pmid: 12119249
references.citation: Circulation. 1999 Jul 27;100(4):376-80
references.pmid: 10421597
references.citation: Circulation. 2000 Sep 19;102(12):1454-60
references.pmid: 10993867
references.citation: Lancet. 1999 Feb 20;353(9153):611-6
references.pmid: 10030325
references.citation: Am Heart J. 2005 Mar;149(3):548-57
references.pmid: 15864246
references.citation: Pacing Clin Electrophysiol. 2003 Jan;26(1P2):295-8
references.pmid: 12687832
references.citation: Am Heart J. 2006 Aug;152(2):217-22
references.pmid: 16875900
references.citation: Circulation. 2003 Jun 17;107(23):2926-31
references.pmid: 12771010
references.citation: J Mol Cell Cardiol. 1995 Sep;27(9):1905-14
references.pmid: 8523451
references.citation: Eur Heart J. 2006 Aug;27(15):1841-6
references.pmid: 16825288
references.citation: Am Heart J. 2004 Jul;148(1):52-61
references.pmid: 15215792
references.citation: Circ Res. 1990 Dec;67(6):1355-64
references.pmid: 1700933
references.citation: Lancet. 2000 Nov 25;356(9244):1789-94
references.pmid: 11117910
references.citation: J Hum Genet. 2002;47(4):184-9
references.pmid: 12166654
references.citation: J Am Coll Cardiol. 2003 Nov 19;42(10):1785-92
references.pmid: 14642689
references.citation: Am J Cardiol. 2007 Jul 15;100(2):247-52
references.pmid: 17631079
references.citation: J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):29-38
references.pmid: 16645357
references.citation: Circulation. 2001 Nov 20;104(21):2608-14
references.pmid: 11714658
references.citation: Circulation. 1997 Aug 19;96(4):1180-4
references.pmid: 9286947
references.citation: JAMA. 2001 May 9;285(18):2370-5
references.pmid: 11343485
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
references.pmid: 15936615
references.citation: Eur Heart J. 2003 Dec;24(23):2090-8
references.pmid: 14643269
references.citation: Eur Heart J. 2006 Aug;27(16):1979-2030
references.pmid: 16885201
references.citation: Circulation. 2006 Mar 14;113(10):1278-86
references.pmid: 16534027
references.citation: Circulation. 2000 Jun 6;101(22):2612-7
references.pmid: 10840013
references.citation: Am J Med. 2002 Oct 1;113(5):359-64
references.pmid: 12401529
references.citation: Circulation. 1997 Oct 7;96(7):2455-61
references.pmid: 9337224
references.citation: J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):114-20
references.pmid: 15526246
references.citation: Am Heart J. 2004 Jan;147(1):121-6
references.pmid: 14691429
references.citation: Am Heart J. 2006 Jul;152(1):86-92
references.pmid: 16838426
references.citation: J Mol Cell Cardiol. 1994 Jul;26(7):809-20
references.pmid: 7966349
references.citation: J Am Coll Cardiol. 2005 Mar 1;45(5):705-11
references.pmid: 15734614
references.citation: Heart Rhythm. 2007 Jun;4(6):743-9
references.pmid: 17556195
references.citation: J Clin Pharmacol. 2006 Jan;46(1):21-8
references.pmid: 16397280
references.citation: Eur Heart J. 2006 Sep;27(17):2062-8
references.pmid: 16891381
references.citation: Circulation. 2004 Apr 6;109(13):1640-6
references.pmid: 15023884